Skip to main content
OpenTrials
Completed

NCT Number: NCT03830840

Mil Familias Cohort Establishment: a Study to Understand Determinants of Diabetes and Its Complications Among US Latinos

The Mil Familias Cohort Establishment involves enrolling 1000 Latino families with at least one member in the family having type 2 diabetes, including children and youth, and measuring the 5 determinants of human health: genetics, biology, behavior, psychology, and society/environment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

7 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sansum Diabetes Research Institute

Santa Barbara, California, 93105, United States

About this study

The vision of Mil Familias is to reduce the burden of cardio-metabolic disease among Latino families in Santa Barbara County and beyond. The aim is to establish an observational cohort of 1,000 Latino families, with at least one family member currently living with diabetes, in order to understand better the impact of the 5 determinants of human health (genetics, biology, behavior, psychology, and society/environment) in this population. Once the 1,000-family cohort is established, evidence-based intervention studies will be developed and implemented based on new knowledge, with collaborators from the healthcare, public policy, academic, pharmaceutical, medical device and technology industries. The strategy involves 4 coordinated and iterative components to achieve its mission:

  • Especialistas: Trusted, bilingual community health workers specially-trained in diabetes education, clinical research methodologies, and care referral. The Especialistas will engage directly with participants to conduct research activities, answer questions, and when necessary, refer participants to appropriate, local community resources.
  • Data: Facilitated by Especialistas, each individual participant will contribute information on up to 100 different variables relating to their genetics, biology, psychology, behavior and society/environment, thus creating a one-of-a-kind database and associated specimen biobank on Latino health and lifestyle ("Living Information Bank").
  • Interventions: Based on the data, evidence-based, collaborative, culturally-relevant prevention and treatment strategies are planned to develop once the cohort of 1,000 families has been established.
  • Allies: This community-based participatory research study requires engagement from key stakeholders from the Latino community, healthcare sectors, hospitals, payers, businesses, people with diabetes and philanthropists. Organizations and individuals support Mil Familias by contributing their resources, experiences, and skill-sets.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males or females ≥ 7 years of age at enrollment.
  • Self-reported Latino heritage.
  • Co-resides with immediate family member (as defined above) OR self with established diagnosis of Type 2 Diabetes for at least one year prior to enrollment date.
  • Signed and dated written informed consent by the date of enrollment.
  • Based on the research staff's judgment, subject or subject's representative must have a good understanding, ability, and willingness to adhere to the protocol, including performance of self-monitored data collection during the wearable device portion.

-

Exclusion criteria

  • Life expectancy < 6 months.
  • Any active clinically significant physical or mental disease or disorder, which in the investigator's opinion could interfere with the participation of the trial.
  • Language barriers precluding comprehension of study activities and informed consent.
  • Participation in other trials involving medication or device within 1 month prior to enrollment.
  • Known or suspected abuse of alcohol, narcotics, or illicit drugs. -

Treatment and study plan

Primary outcomes

  1. Success (evaluated by Yes/No format) recruiting and establishing an observational cohort of 1,000 Latino families with at least one family member living with type 2 diabetes by deploying the methods proven feasible by Mil Familias Operational Pilot.

    Time frame: 3 years

    The Mil Familias Cohort Establishment will expand upon the Mil Familias Operational Pilot cohort and infrastructure to collect and store the up to 100 proposed variables across the 5 determinants of human health to support long-term Mil Familias implementation. The variables pertaining to each participant will be collected and stored at the initial visit and then annually for up to 3 years. Socio-demographic characteristics of the cohort will be described at enrollment by type 2 diabetes status, including age, gender, self-identified race/ethnicity, number of people in household, education, insurance, income, occupation, HbA1c, and country of birth.

Secondary outcomes

  1. Socio-demographics assessed by questionnaire.

    Time frame: Introductory interview/ demographics/ contacts and annually up to 3 years

    Socio-demographics measured by questionnaire - including age, gender, self-identified race/ethnicity, contact information, number in household, income, education, marital status, occupation, caring for elder, night shifts, insurance status, insurance type and payer, influenza immunization status, immigration status, alcohol & tobacco use, birth place,and duration of time in the United States (<5 years, 5-9 years, 10-14 years, 15-19 years, 20-24 years, ≥25 years).

  2. Number of healthcare visits and the difficulty in traveling to the healthcare provider assessed by questionnaire

    Time frame: Introductory interview/ demographics/ contacts and annually up to 3 years

    Number of visits to a healthcare provider in the last year and difficulty in traveling to a healthcare provider measured by interview questionnaire

  3. Questions regarding personal opinions regarding the burden of diabetes on Latinos measured by specific questions

    Time frame: Introductory interview/ demographics/ contacts and annually up to 3 years

    Personal opinion regarding type 2 diabetes burden on Latinos measured by 3 questions - why is diabetes common in Latinos, what can be done to prevent diabetes in Latinos, and what things make it difficult to get help with diabetes when it is needed?

  4. Total daily tortilla consumption

    Time frame: Introductory interview/ demographics/ contacts and annually up to 3 years

    The number of flour and/or corn tortillas consumed daily for the past 30 days is estimated

  5. Daily sugary drink consumption

    Time frame: Introductory interview/ demographics/ contacts and annually up to 3 years

    Daily sugary drink consumption is measured by the 2 questions in the Sugar Sweetened Beverages module of the Behavioral Risk Factor Surveillance System Questionnaire from the Centers for Disease Control.

  6. Number of times per week eating meals prepared away from home

    Time frame: Introductory interview/ demographics/ contacts and annually up to 3 years

    NHANES 2017-2018 question asked - During the past 7 days, how many meals did you get that were prepared away from home in places such as restaurants, fast food places, food stands, grocery stores, or from vending machines?

  7. Laboratory blood draw for evaluation of C-Peptide related to diabetes

    Time frame: Laboratory encounter and annually up to 3 years

    C-Peptide, ng/mL, will measured in a laboratory blood draw sample.

  8. Laboratory blood draw for evaluation of C-Reactive protein related to diabetes

    Time frame: Laboratory encounter and annually up to 3 years

    C-Reactive protein, mg/L, will measured in a laboratory blood draw sample.

  9. Laboratory blood draw for evaluation of Complete Blood Count

    Time frame: Laboratory encounter and annually up to 3 years

    Complete Blood Count will measured in a laboratory blood draw sample.

  10. Laboratory blood draw for evaluation of Comprehensive Metabolic Panel

    Time frame: Laboratory encounter and annually up to 3 years

    Comprehensive Metabolic Panel will measured in a laboratory blood draw sample.

  11. Laboratory blood draw for evaluation of Glutamic Acid Decarboxylase (GAD) antibodies related to diabetes

    Time frame: Laboratory encounter and annually up to 3 years

    Glutamic Acid Decarboxylase (GAD) antibodies, U/mL, will measured in a laboratory blood draw sample.

  12. Laboratory blood draw for evaluation of HbA1c related to diabetes

    Time frame: Laboratory encounter and annually up to 3 years

    HbA1c % will measured in a laboratory blood draw sample.

  13. Laboratory blood draw for evaluation of Insulin autoantibody related to diabetes

    Time frame: Laboratory encounter and annually up to 3 years

    Insulin autoantibody, U/mL, will measured in a laboratory blood draw sample.

  14. Laboratory blood draw for evaluation of Islet antigen 2 (IA-2) antibody related to diabetes

    Time frame: Laboratory encounter and annually up to 3 years

    Islet antigen 2 (IA-2) antibody, U/mL, will measured in a laboratory blood draw sample.

  15. Laboratory blood draw for evaluation of lipids

    Time frame: Laboratory encounter and annually up to 3 years

    Lipids will measured in a laboratory blood draw sample.

  16. Laboratory blood draw for evaluation of Insulin

    Time frame: Laboratory encounter and annually up to 3 years

    Insulin, milliunits/L, will measured in a laboratory blood draw sample.

  17. Laboratory blood draw for evaluation of thyroid function

    Time frame: Laboratory encounter and annually up to 3 years

    Thyroid function will measured in a laboratory blood draw sample.

  18. Microalbumin measured in a urine sample

    Time frame: Laboratory encounter and annually up to 3 years

    Urine sample collected for measuring microalbumin mg/L

  19. Creatinine measured in a urine sample

    Time frame: Laboratory encounter and annually up to 3 years

    Urine sample collected for measuring creatinine

  20. Microalbumin/creatinine ratio measured in a urine sample

    Time frame: Laboratory encounter and annually up to 3 years

    Urine sample collected for measuring the microalbumin/creatinine ratio

  21. Cheek cells and saliva for genomic analysis

    Time frame: Laboratory encounter and annually up to 3 years

    Cheek epithelial cells from a swab and saliva samples will be collected for genetic analysis

  22. Stool samples for microbiome analysis

    Time frame: Laboratory encounter and annually up to 3 years

    Stool/fecal samples will be collected for microbiome analysis

  23. Height measured by Physical exam

    Time frame: Physical exam encounter and annually up to 3 years

    Height measured in centimeters or inches by physical exam

  24. Weight measured by Physical exam

    Time frame: Physical exam encounter and annually up to 3 years

    Weight measured in kilograms or pounds by physical exam

  25. Waist circumference measured by Physical exam

    Time frame: Physical exam encounter and annually up to 3 years

    Waist circumference measured in centimeters or inches by physical exam

  26. Blood pressure measured by Physical exam

    Time frame: Physical exam encounter and annually up to 3 years

    Blood pressure, systolic and diastolic, measured in mmHg by physical exam

  27. Temperature measured by Physical exam

    Time frame: Physical exam encounter and annually up to 3 years

    Temperature measured in degrees by physical exam

  28. Heart rate measured by Physical exam

    Time frame: Physical exam encounter and annually up to 3 years

    Heart rate measured in beats per minute by physical exam

  29. Foot examination evaluated by Questions and Physical exam

    Time frame: Physical exam encounter and annually up to 3 years

    Foot examination with yes or no questions and by physical exam

  30. Neuropathy Questions during Physical exam

    Time frame: Physical exam encounter and annually up to 3 years

    Questions about neuropathy

  31. Retinopathy questions during Physical exam

    Time frame: Physical exam encounter and annually up to 3 years

    Questions about retinopathy

  32. Dental exam Questions during Physical exam

    Time frame: Physical exam encounter and annually up to 3 years

    Questions about dental exams

  33. Eye exam Questions during Physical exam

    Time frame: Physical exam encounter and annually up to 3 years

    Questions about eye exams

  34. Medical history, family medical history, and medication status and history assessed by interview

    Time frame: Physical exam encounter and annually up to 3 years

    Medical history including date of diabetes diagnosis, family medical history, and current medications verified by visual inspection and medication history assessed by interview questionnaire

  35. Menopausal status, pregnancy status, and gestational diabetes history for women determined by interview

    Time frame: Physical exam encounter and annually up to 3 years

    Menopausal status, pregnancy status (number of live births, number of stillbirths, birthweights of live births, and any diagnosis of type 1 diabetes), and gestational diabetes history for female participants will be determined by interview

  36. Determination of diabetes related foot disease

    Time frame: Questionnaires encounter and annually up to 3 years

    Questionnaire for determination of diabetes related foot disease (Q-DFD)

  37. Acculturation measured by the Brief Acculturation Scale for Hispanics (BASH)

    Time frame: Questionnaire encounter and annually up to 3 years

    BASH is a participant reported questionnaire to measure acculturation. Responses are scored as 1 = only Spanish, 2 = Spanish more than English, 3 = Spanish and English equally, 4 = English more than Spanish, and 5 = only English. Items are summed and divided by the number of items. Low acculturation is less than or equal to 3.0, and high acculturation is greater than or equal to 3.0.

  38. Quality of life measured by the Short Form Health Survey (SF-12)

    Time frame: Questionnaires encounter and annually up to 3 years

    The SF-12 is a participant reported questionnaire to measure quality of life

  39. Depression measured by the Patient Health Questionnaire-9

    Time frame: Questionnaires encounter and annually up to 3 years

    The Patient Health Questionnaire (PHQ)-9 is the Major Depressive Disorder (MDD) module of the full PHQ

  40. Perceived Ethnic Discrimination measured by the Brief Perceived Ethnic Discrimination Questionnaire - Community version (PEDQ-CV)

    Time frame: Questionnaires encounter and annually up to 3 years

    PEDQ-CV is a participant reported questionnaire to measure perceived ethnic discrimination

  41. Adverse Childhood Experiences (ACE) quantified by ACE questionnaire

    Time frame: Questionnaires encounter and annually up to 3 years

    Adverse Childhood Experiences (ACEs) refers to a range of events that a child can experience, which lead to stress and can result in trauma and chronic stress responses. An ACE score will be quantified by a specific ACE questionnaire.

  42. Spirituality measured by a Spiritual Well Being Scale

    Time frame: Questionnaires encounter and annually up to 3 years

    FACIT" (Functional Assessment of Chronic Illness Therapy) Sp-12 is a questionnaire for measuring spiritual well being. Questions are scored from 0 = Not at all to 4 = Very much. Sub-scales are created for meaning, peace, and faith with score ranges of 0 - 16. Adding these 3 scores gives a total score and the range is 0 - 48 with low scores indicating low spiritual well being and high scores indicating higher spiritual well being.

  43. Risk Perception Survey For Developing Diabetes (RPS-DD)

    Time frame: Questionnaires encounter and annually up to 3 years

    Diabetes risk perception will be measured by the Risk Perception Survey For Developing Diabetes (RPS-DD)

  44. Sleep quality measured by the Oviedo Sleep Questionnaire (OSQ)

    Time frame: Questionnaires encounter and annually up to 3 years

    The OSQ is a participant reported questionnaire to measure sleep quality

  45. Stress measured by the 4 item Perceived Stress Scale (PSS)

    Time frame: Questionnaires encounter and annually up to 3 years

    PSS is a participant reported questionnaire to measure stress. The scale ranges from 0 = never to 4 = very often. The final score ranges from 0 - 16, with higher scores indicating more stress.

  46. Drug abuse measured by the Drug Abuse Screening Test (DAST) - 20

    Time frame: Questionnaires encounter and annually up to 3 years

    The purpose of the DAST-20 is to provide a brief, simple, practical, but valid method for identifying individuals who are abusing psychoactive drugs; and to yield a quantitative index score of the degree of problems related to drug use and misuse

  47. Diabetes management measured by the Diabetes Symptom Self-Care Inventory

    Time frame: Questionnaires encounter and annually up to 3 years

    Ability to manage diabetes self-care assessed by the Diabetes Symptom Self-Care Inventory (DSSCI)

  48. Family diabetes management measured by questionnaire

    Time frame: Questionnaires encounter and annually up to 3 years

    Family diabetes Self-Efficacy for management of diabetes measured by questionnaire (FSE)

  49. Foot self care confidence measured by questionnaire

    Time frame: Questionnaires encounter and annually up to 3 years

    Foot Care Confidence Scale (FCCS) is an instrument designed to measure the confidence (self-efficacy) of individuals with type 2 diabetes to perform foot self care

  50. Health literacy measured by the Short Assessment of Health Literacy (SAHL)

    Time frame: Questionnaires encounter and annually up to 3 years

    SAHL is a participant reported questionnaire to measure health literacy

  51. Measurement of health numeracy

    Time frame: Questionnaires encounter and annually up to 3 years

    Newest Vital Sign (NVS) is a tool to assess health literacy and numeracy in English and Spanish

  52. Trust in physician measured by the Trust in Physician (TPS) questionnaire

    Time frame: Questionnaires encounter and annually up to 3 years

    The TPS is a questionnaire and scale to determine trust in the physician

  53. Social needs screening assessed by the Health Leads Screening toolkit

    Time frame: Questionnaires encounter and annually up to 3 years

    The Health Leads Screening tookit (Boston, MA) will be used to determine social needs - housing instability, childcare, utility needs, financial resource strain, transportation, and exposure to violence.

  54. Food security assessed by U.S. Household Food Security Survey Module: Six-item short form

    Time frame: Questionnaires encounter and annually up to 3 years

    Food security or insecurity assessed by a six-item short form developed by the Economic Research Service, United States Department of Agriculture (USDA), September 2012

  55. Functional support measured by the SSQ6

    Time frame: Questionnaires encounter and annually up to 3 years

    Social Support Questionnaire - Short Form (SSQ6) measures functional social support

  56. Support structure measured by Medical Outcomes Study Social Support Survey (mMOS-SS)

    Time frame: Questionnaires encounter and annually up to 3 years

    The eight-item modified Medical Outcomes Study Social Support Survey (mMOS-SS) measures support structure by counting the number of people supporting and satisfaction with that support

  57. National survey of children's health (NSCH) for all children and youth

    Time frame: Questionnaires encounter and annually up to 3 years

    The NSCH, a validated survey of children's health and translated into Spanish, will assess health of children and youth

Other outcomes

  1. Physical activity measured by two wearable physical activity monitors for 1 week

    Time frame: On-going activity encounter up to twice in 1 year

    Participants wear an ActiGraph and Fitbit activity monitors simultaneously for 1 week, complete an activity log, and answer a user experience questionnaire.

Sponsors and collaborators

Lead sponsor

Sansum Diabetes Research Institute

Other

Collaborators

  • Eli Lilly and Company

Registry information

Official study title

Mil Familias: an Observational Cohort Study to Understand the Impact of Genetics, Biology, Behavior, Psychology, and Society/Environment on Diabetes and Its Complications Among US Latinos

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Feb 5, 2019
Registry last updated
Jun 6, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.